A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection-Reference-Cited by-同舟云学术

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection

Published:2014-03-01 Issue:3 Volume:65 Page:e121-e124
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Clumeck Nathan,Molina Jean-Michel,Henry Keith,Gathe Joseph,Rockstroh Jürgen K.,DeJesus Edwin,Wei Xuelian,White Kirsten,Fordyce Marshall W.,Rhee Martin S.,Szwarcberg Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference7 articles.

1. . A randomized, double-blind comparison of co-formulated elvitegravircobicistatemtricitabinetenofovir versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.;Rockstroh;J Acquir Immune Defic Syndr,2013

2. . A randomized double-blind comparison of coformulated elvitegravircobicistatemtricitabinetenofovir disoproxil fumarate versus efavirenzemtricitabinetenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 results.;Zolopa;J Acquir Immune Defic Syndr,2013

3. . Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.;DeJesus;Lancet,2012

4. . Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.;Cohen;Lancet,2011

5. . Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.;Molina;Lancet,2011

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter;Biomedicines;2024-04-20

2. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection;Retrovirology;2022-10-22

3. Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting;African Health Sciences;2021-12-14

4. Integrase strand transfer inhibitors can simplify HIV treatment;Drugs & Therapy Perspectives;2021-06-30

5. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance;International Journal of Antimicrobial Agents;2021-05